Corbus Pharmaceuticals Holdings (CRBP) Other Non-Current Assets (2014 - 2025)

Corbus Pharmaceuticals Holdings' Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.8 million for Q4 2025.

• In Q4 2025, Other Non-Current Assets rose 368.83% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (up 368.83% YoY), while the FY2025 annual figure was $1.8 million, up 368.83% from the prior year.
• Other Non-Current Assets was $1.8 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $385000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.8 million in Q4 2025 to a low of $2614.0 in Q2 2021.
• Historically, Other Non-Current Assets has averaged $430337.8 across 5 years, with a median of $385000.0 in 2024.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets plunged 93.08% in 2021, then surged 18164.15% in 2022.
• A 5-year view of Other Non-Current Assets shows it stood at $46385.0 in 2021, then surged by 234.91% to $155346.0 in 2022, then soared by 36.47% to $212000.0 in 2023, then surged by 81.6% to $385000.0 in 2024, then soared by 368.83% to $1.8 million in 2025.
• The last three Other Non-Current Assets figures came in at $1.8 million (Q4 2025), $385000.0 (Q3 2025), and $385000.0 (Q2 2025), per Business Quant data.